Chaim G Pick
Chaim G Pick is an expert in Neurology at Tel Aviv University (Israel). As of July 2026, ScienceLeadR ranks Chaim G Pick in the top 1% of experts worldwide for Brain Injuries. Chaim G Pick has authored 244 publications, the most recent in 2025. SLR score: 679 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Pharmacy - Psychology - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1984 - 2026
Number : 244
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)? PMID 40006022 — depression, antidepressive agents, reboxetine, receptors, opioid, kappa, narcotic antagonists, mirtazapine, amisulpride, receptors, opioid, risperidone, mianserin, therapeutics, depressive disorder, treatment-resistant, zolpidem | Pharmaceuticals (Basel) | 2025 | 0 |
| Multi-Planar Cervical Motion Dataset: IMU Measurements and Goniometer. PMID 39753563 — research design, multiple chronic conditions, information storage and retrieval, movement, spine | Sci Data | 2025 | 0 |
| Enhancing cognitive function after traumatic brain injury in male mice: The benefits of running regardless of intervention timing. PMID 39577609 — exercise, brain injuries, spatial memory, brain, running, brain injuries, traumatic, memory, wounds and injuries, neurology, cognition | Exp Neurol | 2024 | 4 |
| Investigation of Mild Traumatic Brain Injury Home Cage Behavior: The Home Cage Assay Advantages. PMID 38517091 — brain injuries, brain, running, spinal cord injuries, reversal learning, brain injuries, traumatic, learning | J Neurotrauma | 2024 | 2 |
| Corrigendum to "Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury" [Neurobiology of Disease Volume 124 (2019) 439-453 /YNBDI_4338]. PMID 38890024 — pharmacokinetics, neurobiology, brain injuries, traumatic, exenatide | Neurobiol Dis | 2024 | 0 |
LeadR Networks
Main global connection map